INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 22 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 18,590,000 | $11,232,000 | 0.16% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5,175,000 | $3,118,000 | 0.07% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 225,000 | $136,000 | 0.02% |
Calamos Advisors LLC | 5,000,000 | $3,012,000 | 0.01% |
FRANKLIN RESOURCES INC | 21,000,000 | $12,846,000 | 0.01% |
FMR LLC | 17,435,000 | $10,534,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 4,426,000 | $2,545,000 | 0.00% |